Cefazolin and Neurontin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Neurontin (gabapentin). Common drug interactions include anaemia among females and renal failure acute among males.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Neurontin. It is created by eHealthMe based on reports of 187 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
187 people who take Cefazolin and Neurontin together, and have interactions are studied.
What are the common drug interactions of Cefazolin and Neurontin, by gender? *
What are the common drug interactions of Cefazolin and Neurontin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin and Neurontin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cefazolin and Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neurontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and gabapentin (the active ingredients of Cefazolin and Neurontin, respectively), and Cefazolin and Neurontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tylenol and Uti for Men aged 40-49 - 4 seconds ago
- Tylenol and Cystitis for Men aged 40-49 - 5 seconds ago
- Tylenol and Bladder Infection for Men aged 40-49 - 5 seconds ago
- Tylenol and Urinary Tract Infection for Men aged 40-49 - 5 seconds ago
- Zopiclone and Gastrooesophageal Reflux Disease for Women aged 60+ - 6 seconds ago
- Zopiclone and Gastro-Oesophageal Reflux Disease for Women aged 60+ - 6 seconds ago
- Zopiclone and Reflux for Women aged 60+ - 6 seconds ago
- Zopiclone and Heartburn for Women aged 60+ - 7 seconds ago
- Zopiclone and Non-Cardiac Chest Pain for Women aged 60+ - 7 seconds ago
- Zopiclone and Gerds for Women aged 60+ - 7 seconds ago